ERBB2 and cancer: Namely, the developed two-step DDS based on barnase*barstar showed superior efficiency in image-guided cancer therapy: HER2-positive tumors’ treatment tests showed the tumor growth inhibition index TGI = 68.4% for one-step DDS and TGI = 94.9% for two-step DDS.